Baxter Shares Outstanding 2010-2025 | BAX
Baxter shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Baxter shares outstanding for the quarter ending March 31, 2025 were 514M, a 0.78% increase year-over-year.
- Baxter 2024 shares outstanding were 0.51B, a 0.39% increase from 2023.
- Baxter 2023 shares outstanding were 0.508B, a 0.79% increase from 2022.
- Baxter 2022 shares outstanding were 0.504B, a 0.79% decline from 2021.
| Baxter Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 510 |
| 2023 | 508 |
| 2022 | 504 |
| 2021 | 508 |
| 2020 | 517 |
| 2019 | 519 |
| 2018 | 546 |
| 2017 | 555 |
| 2016 | 551 |
| 2015 | 549 |
| 2014 | 547 |
| 2013 | 549 |
| 2012 | 556 |
| 2011 | 573 |
| 2010 | 594 |
| 2009 | 614 |
| Baxter Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 514 |
| 2024-12-31 | 510 |
| 2024-09-30 | 512 |
| 2024-06-30 | 510 |
| 2024-03-31 | 510 |
| 2023-12-31 | 508 |
| 2023-09-30 | 509 |
| 2023-06-30 | 506 |
| 2023-03-31 | 505 |
| 2022-12-31 | 504 |
| 2022-09-30 | 504 |
| 2022-06-30 | 508 |
| 2022-03-31 | 509 |
| 2021-12-31 | 508 |
| 2021-09-30 | 506 |
| 2021-06-30 | 509 |
| 2021-03-31 | 511 |
| 2020-12-31 | 517 |
| 2020-09-30 | 518 |
| 2020-06-30 | 517 |
| 2020-03-31 | 516 |
| 2019-12-31 | 519 |
| 2019-09-30 | 520 |
| 2019-06-30 | 519 |
| 2019-03-31 | 522 |
| 2018-12-31 | 546 |
| 2018-09-30 | 546 |
| 2018-06-30 | 547 |
| 2018-03-31 | 551 |
| 2017-12-31 | 555 |
| 2017-09-30 | 557 |
| 2017-06-30 | 555 |
| 2017-03-31 | 551 |
| 2016-12-31 | 551 |
| 2016-09-30 | 551 |
| 2016-06-30 | 553 |
| 2016-03-31 | 552 |
| 2015-12-31 | 550 |
| 2015-09-30 | 549 |
| 2015-06-30 | 549 |
| 2015-03-31 | 548 |
| 2014-12-31 | 547 |
| 2014-09-30 | 547 |
| 2014-06-30 | 548 |
| 2014-03-31 | 548 |
| 2013-12-31 | 548 |
| 2013-09-30 | 549 |
| 2013-06-30 | 549 |
| 2013-03-31 | 551 |
| 2012-12-31 | 556 |
| 2012-09-30 | 552 |
| 2012-06-30 | 553 |
| 2012-03-31 | 563 |
| 2011-12-31 | 573 |
| 2011-09-30 | 571 |
| 2011-06-30 | 575 |
| 2011-03-31 | 581 |
| 2010-12-31 | 594 |
| 2010-09-30 | 587 |
| 2010-06-30 | 596 |
| 2010-03-31 | 602 |
| 2009-12-31 | 614 |
| 2009-09-30 | 612 |
| 2009-06-30 | 612 |
| 2009-03-31 | 621 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $15.752B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||